Phase II study of bortezomib in patients with previously treated advanced urothelial tract transitional cell carcinoma: CALGB 90207
- Citation:
- Ann Oncol vol 19 (5) 946-950
- Year:
- 2008
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pmc-release
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Book Volume:
- Parents:
- None
- Children:
- None
- Pharmas:
- Grants:
- Corr. Author:
- Authors:
- J. E. Rosenberg S. Halabi B. L. Sanford A. L. Himelstein J. N. Atkins R. J. Hohl F. Millard D. F. Bajorin E. J. Small
- Networks:
- Study
- CALGB-90207
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 2
- Keywords: